Increase in fibrinolytic activity after erythropoietin therapy.
Szewczuk
J
J
Mazerska
M
M
Malyszko
J
J
Kalinowski
M
M
Mysliwiec
M
M
D000328:Adult; D000368:Aged; D001760:Bleeding Time; D004921:Erythropoietin / Q000009:adverse effects*; D005342:Fibrinolysis / Q000187:drug effects*; D006801:Humans; D008875:Middle Aged; D011994:Recombinant Proteins / Q000009:adverse effects
D011994:Recombinant Proteins; D004921:Erythropoietin